skinny.

Latest / The National Briefing

A powerful new tool in the fight against HIV has arrived, but whether South Africa can afford it remains uncertain. The FDA’s recent approval of Lenacapavir, a biannual injectable HIV prevention drug, has sparked hope and debate.

Guest: Sibongile Tshabalala: Chairperson, Treatment Action Campaign & HIV Activist

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.